Cite
HARVARD Citation
Bigenzahn, S. et al. (n.d.). No augmentation of indoleamine 2, 3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients. Clinical and experimental immunology. pp. 233-241. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bigenzahn, S. et al. (n.d.). No augmentation of indoleamine 2, 3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients. Clinical and experimental immunology. pp. 233-241. [Online].